Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Researchers clarifiy role of Notch protein in T-cell development

Researchers at the University of Pennsylvania School of Medicine have recently clarified the role of the Notch protein in T-cell development. T cells are required for many aspects of immunity, including fighting viral infections, providing cancer surveillance, and regulating multiple aspects of the immune response.

6 Jul 2005

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

6 Jul 2005

Doctors are able to predict sterility in women following radiation treatment for cancer

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile, according to a new study.

4 Jul 2005

Acetylsalicylic acid, the active ingredient in Aspirin can lower the risk of redeveloping colorectal cancer

Acetylsalicylic acid, the active ingredient in Aspirin®, can lower the risk of redeveloping colorectal cancer: Stage III colon cancer patients, who have undergone surgery and chemotherapy, experience less recurrence and fatalities when using Aspirin®.

4 Jul 2005

Preclinical data suggest CuraGen's Velafermin may protect the gastrointestinal tract and decrease associated toxicity following exposure to radiation

New preclinical data on velafermin (CG53135), CuraGen's Phase II clinical product being developed for the prevention of oral mucositis (OM), suggesting that velafermin may protect the gastrointestinal tract and decrease associated toxicity, including enteritis and diarrhea, following exposure to radiation.

1 Jul 2005

Pomegranate juice may help babies resist brain injuries from low oxygen

Expectant mothers at risk of premature birth may want to consider drinking pomegranate juice to help their babies resist brain injuries from low oxygen and reduced blood flow, a new mouse study from Washington University School of Medicine in St. Louis suggests.

28 Jun 2005

Tricirbine may help fight cancers

H. Lee Moffitt Cancer Center & Research Institute, working in partnership with the University of South Florida (USF), has discovered a new use for an old, previously discredited anti-cancer drug that could add another weapon in the arsenal against several cancers, including tumors of the breast, ovary, colon, skin and prostate.

27 Jun 2005

New low-cost technology that allows thousands of tumor slices to be screened side-by-side

Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have devised a new low-cost technology that allows thousands of tumor slices to be screened side-by-side, an improvement over current and more expensive methods that can analyze only several hundred tumors at once.

27 Jun 2005

Double whammy of chemo plus surgery extends life for lung cancer patients

Recent research which has shown that chemotherapy can significantly lengthen life in many patients with lung cancer, has meant that doctors, for the first time in decades, have begun making major changes in the treatment of the disease.

23 Jun 2005

The CMS demonstration project in oncology

The PricewaterhouseCoopers study that the Community Oncology Alliance (COA) commissioned shows that an estimated $13 billion will be saved from Medicare spending for cancer care through 2013. This is $8.8 billion more than the original intent of Congress in passing the Medicare Modernization Act (MMA).

22 Jun 2005

Some men with breast cancer may be having unnecessary radiotherapy

A study carried out at the British Columbia Cancer Agency in Vancouver, British Columbia, Canada, showed that men whose cancer had not spread beyond the breast were almost six times more likely to be given radiotherapy than were women with the equivalent stage of disease.

21 Jun 2005

Keyhole surgery can be safely used for the removal of tumours from the colon

The safety and short-term benefits of keyhole surgery for colon cancer have been debatable. Minimally invasive surgery for cancer reduces surgical trauma but there has been concern that it could lead to tumour recurrence.

20 Jun 2005

New discoveries in treatment for patients with non-Hodgkin's lymphoma

Three scientific studies - each highlighting new discoveries in treatment for patients with non-Hodgkin's lymphoma - were announced at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

Stem cells grown in lab mirror normal developmental steps

Johns Hopkins scientists have developed a way to study the earliest steps of human blood development using human embryonic stem cells grown in a lab dish instead of the embryos themselves.

20 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

Monitoring and fine tuning the levels of the cancer drug topotecan in children with neuroblastoma holds promise for maximizing the drug's effectiveness while reducing its toxicity, according to investigators at St. Jude Children's Research Hospital.

19 Jun 2005

High-volume medical centers better at treating cancer

Patients with certain complex cancers fare better under the care of doctors and hospitals that do the most of that kind of surgery, a new review of studies finds.

19 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

16 Jun 2005

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

Wonder drug attacks range of cancers

A team of cancer research scientists from the Royal Marsden Hospital in London say the drug 17AAG has shown in early trials, promising signs of fighting a range of cancers.

16 Jun 2005